Aviva has been a steady name in UK insurance for years, yet its share price swings still catch investors off guard — especially when analyst targets diverge sharply from current levels. If you’re weighing whether to hold, buy, or watch from the sidelines, the numbers matter more than the headline chatter. Here’s what the data actually shows.

Current Price: 641.00p · Open: 638.80p · Day’s High: 641.20p · Previous Close: 644.10p · Bid: 639.00p

Quick snapshot

1Live Price
2Forecasts
3Performance
4Valuation
  • Market cap: £19.45 billion · P/E: 24.31 (AJ Bell)
  • Dividend yield: 6.1% (AJ Bell)

The table below consolidates key trading and fundamental metrics for Aviva PLC ordinary shares on the London Stock Exchange.

Metric Value
Ticker AV.
Exchange LSE
Current Price 641.00p
Share Type Ordinary Shares 32 17/19 pence
Day’s Range 635.40 – 641.30p
52-Week Range 525.00p – 701.00p
Market Cap £19.45 billion
P/E Ratio 24.31
Dividend Yield 6.1%
Beta 1.1

What is today’s price for Aviva shares?

Aviva shares were trading at 641.00p at time of writing, according to GuruFocus (real-time LSE data). The stock opened at 638.80p and has moved between 635.40p and 641.30p during the session so far. The previous close was 644.10p.

Live LSE quote

The bid sits at 639.00p, suggesting a modest gap between buying and selling pressure in early trading. For context, the 52-week high stands at 701.00p while the 52-week low is 525.00p — placing today’s level comfortably within that range.

Recent trading range

The 14-day RSI reads 64.02, according to GuruFocus, which indicates the stock is neither overbought nor oversold. Volatility has been relatively contained at 17.36% over the measured period.

Bid and ask prices

Spread between bid (639.00p) and the current price (641.00p) reflects normal market depth for a FTSE 250 constituent. The 14 analysts offering 12-month price targets, as tracked by Investors Chronicle, collectively suggest a median upside of roughly 8.9% from here.

The current price sits near the lower half of its annual range, giving holders who bought earlier meaningful unrealised gains while keeping entry points accessible for new investors.

What is the prediction for Aviva stock?

Analyst sentiment on Aviva skews cautiously constructive. The median 12-month price target is 697.75 pence, according to Investors Chronicle, which represents roughly 8.92% upside from the last traded price of 640.60 pence. Fourteen analysts are currently covering the stock.

Short-term outlook

The consensus recommendation as of 12 March 2026 breaks down as follows: 3 Buy ratings, 6 Outperform, 6 Hold, and 1 Sell with zero Strong Sell calls, per Investors Chronicle. MarketBeat reports a Moderate Buy consensus based on its own polling of four analysts.

Analyst targets

Individual targets span a wide range. The high target of 770.00 pence from Investors Chronicle implies over 20% potential gains, while the low target of 543.00 pence would represent a meaningful decline from current levels. MarketBeat puts the average 12-month target from five analysts at 711.20 pence, with the highest single target reaching 760 pence.

Key factors influencing

Earnings are forecast to grow 14.48% per year, per Simply Wall St, while actual earnings grew 21.2% over the past year. Revenue for the trailing twelve months came in at £31,760 million, according to GuruFocus. The P/E ratio of 24.31 (AJ Bell) sits at a level that leaves room for valuation expansion if growth sustains.

The wide spread between targets reflects genuine disagreement about near-term direction. Investors should weigh the growth trajectory against macro headwinds in the insurance sector.

What this means: the analyst consensus leans positive but is not unanimous — the wide spread between targets reflects genuine disagreement about near-term direction. Investors should weigh the growth trajectory against macro headwinds in the insurance sector.

Is it worth keeping Aviva shares?

For income-focused investors, Aviva’s 6.1% dividend yield — verified by AJ Bell — makes a compelling case to hold. Over the past year, the share price has risen 22.31%, per Simply Wall St, meaning investors have received both income and capital appreciation.

Pros and cons

Upsides

  • 6.1% dividend yield outpaces most FTSE 250 peers and many savings products
  • 21.2% earnings growth in the past year demonstrates operational momentum
  • 14.48% annual earnings growth forecast suggests future profit expansion
  • Trading 46.2% below fair value estimates (Simply Wall St)

Downsides

  • One analyst rate it a Sell, flagging downside risk to targets
  • P/E of 24.31 is above sector average — limited margin of safety
  • Beta of 1.1 means above-market volatility
  • Revenue compound annual growth rate has been negative (-4%) over 13 years (Alpha Spread)

The implication: Aviva rewards income investors who can tolerate the elevated volatility, but growth seekers should verify that the revenue slide has stabilised before treating the discount to fair value as a value trap solved.

Historical performance

The one-month price change stands at 5.59%, per Simply Wall St. The stock’s 3-year Sharpe ratio of 0.52, per GuruFocus, indicates reasonable risk-adjusted returns relative to a simple equity portfolio, though not exceptional.

Dividend yield

At 6.1%, the dividend yield is the headline figure for income investors. With 2,660.84 million shares outstanding and a market capitalisation of £19.45 billion, the company has the scale to sustain distributions — but the insurance sector’s exposure to catastrophe claims and investment losses means yield is never guaranteed.

The trade-off: Aviva offers a high-yield buffer against price volatility, but the P/E premium and revenue stagnation history mean holders are betting on earnings growth, not turnarounds.

What is the Aviva forecast for 2026?

Longer-term projections point to continued earnings expansion. The median 12-month target from 14 analysts sits at 697.75 pence, as tracked by Investors Chronicle. Alpha Spread reports the average 1-year price target from Wall Street analysts at 673.4 pence, with a high forecast of 777 pence and a low of 548.43 pence.

Long-term projections

Earnings are forecast to grow at 14.48% per year according to Simply Wall St. At that rate, a £10,000 investment would compound to roughly £16,300 over five years before dividends, assuming the forecast holds and the multiple doesn’t contract. Whether that projection materialises depends heavily on claims experience and investment returns in the broader economy.

House view from Aviva Investors

Aviva’s own investor relations materials highlight capital management discipline and cost-efficiency programmes as key drivers. The company has consistently returned excess capital to shareholders through buybacks and dividends, though the market cap of £19.45 billion, per AJ Bell, suggests it remains a mid-tier insurer by global standards.

Market outlook

Technical analysis on TradingView rates Aviva PLC as a buy on both short-term and weekly charts, with the prevailing trend showing buy signals across timeframes. The 14-day RSI of 64.02 from GuruFocus supports this view without reaching overbought territory.

The catch: analysts expect growth, but the wide target spread (548.43p to 777p) signals that roughly 20% downside is plausible if macro conditions deteriorate or catastrophe claims spike.

Are Aviva shares likely to go up?

The bullish case rests on three pillars: a 6.1% dividend yield that attracts income buyers, consistent earnings growth (21.2% last year, 14.48% forecast), and a valuation that Simply Wall St estimates sits 46.2% below fair value. The 22.31% one-year return, per the same source, shows the market has already rewarded recent performance.

Recent trends

The one-month gain of 5.59% and 14-day RSI of 64.02 indicate momentum without exhaustion. The 52-week range of 525.00p to 701.00p frames current levels around the midpoint, leaving room for both further upside and pullbacks.

News impact

Research notes indicate limited recent news coverage of major announcements, which is typical for a mature insurer rather than a high-growth tech name. Insurance sector stocks tend to react more to macroeconomic signals — interest rates, catastrophe events, regulatory changes — than to company-specific headlines.

Potential risks

The revenue compound annual growth rate of -4% over 13 years, flagged by Alpha Spread, is a red flag for investors focused on top-line expansion. Negative revenue growth over such a long period suggests structural pressures — possibly from market share loss, deprecation of legacy books, or strategic divestitures — that earnings growth alone may not address.

For UK investors, the picture is mixed: Aviva offers reliable income and recent earnings momentum, but the long revenue decline and wide analyst target spread mean that “going up” is neither guaranteed nor uniform across timeframes.

The upshot

For income-focused UK investors holding long term, the 6.1% dividend yield beats most savings products — but the P/E of 24.31 and analyst target spread (543p to 777p) mean price appreciation depends on the growth story playing out, not merely the yield holding.

Bottom line: UK investors prioritising income over capital gains get a 6.1% yield that beats most savings products — but growth-oriented investors demanding proof of revenue stabilisation should treat the 14.48% earnings forecast and 46.2% discount to fair value as potential rather than certainty.

Related reading: Best Mortgage Rates UK · Small Claims Court UK

Investors eyeing Aviva’s 641.00p LSE quote and 6.1% yield can delve into the Aviva UK share price guide for complementary charts and buy strategies.

Frequently asked questions

How much are 72 Aviva shares worth today?

At the current price of 641.00p per share, 72 shares are worth approximately £461.52. Use a broker platform or calculator at AJ Bell for live conversions to euros or other currencies.

What is wrong with Aviva shares?

There is no fundamental “problem” with Aviva shares per se. The 6.1% dividend yield and 21.2% earnings growth indicate a functioning business. The concerns are the P/E premium at 24.31, the long-term revenue decline (-4% CAGR over 13 years per Alpha Spread), and the wide analyst target spread, which signals uncertainty about near-term direction.

Aviva share price in euro?

Aviva is denominated in pound sterling on the LSE. As of writing, with GBP/EUR around 1.17, the 641.00p price translates to approximately €7.50 per share. Check AJ Bell for real-time conversions.

Aviva share price LSE chart?

Interactive charts for Aviva on the LSE are available at TradingView, GuruFocus, and most UK broker platforms. Chart patterns show a 52-week range of 525.00p–701.00p with current price near the midpoint.

£7,500 invested in Aviva shares 5 years ago is now worth…?

Using the 22.31% one-year return from Simply Wall St as a proxy (excluding dividends), a £7,500 investment five years ago would have grown to roughly £13,175 assuming consistent compounding — though actual returns depend on entry timing and dividend reinvestment. A specific calculator at Simply Wall St can model your exact position.

Aviva share price calculator?

Most UK brokers offer share calculators. Simply Wall St provides fair value estimates alongside portfolio modelling tools. Input your share count and current price to project potential returns based on analyst targets.

Aviva share price LSE news?

Latest LSE-specific news for Aviva is available through Investors Chronicle and the London Stock Exchange website. Broker platforms like AJ Bell aggregate RNS (Regulatory News Service) announcements in real time.

Aviva share price LSE 2022?

Research notes indicate that specific 2022 price history is not included in the current data set. The 52-week low of 525.00p and long-term revenue growth data suggest Aviva traded lower in prior years during periods of sector pressure. Check GuruFocus historical charts for full 2022 records.